Industry News
Immune Modifying Nanoparticles Reduce Heart Attack Damage
January 22nd 2014Cour Pharmaceutical Development Company, a biopharmaceutical company, has published new data showing that its proprietary nanoparticle therapy could potentially reduce inflammation and promote tissue repair and regeneration in patients who have had a heart attack.